Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
32 results about "Phorbol" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Phorbol is a natural, plant-derived organic compound. It is a member of the tigliane family of diterpenes. Phorbol was first isolated in 1934 as the hydrolysis product of croton oil, which is derived from the seeds of the purging croton, Croton tiglium. The structure of phorbol was determined in 1967. Various esters of phorbol have important biological properties, the most notable of which is the capacity to act as tumor promoters through activation of protein kinase C. They mimic diacylglycerols, glycerol derivatives in which two hydroxyl groups have reacted with fatty acids to form esters. The most common and potent phorbol ester is 12-O-tetradecanoylphorbol-13-acetate (TPA), also called phorbol-12-myristate-13-acetate (PMA), which is used as a biomedical research tool in contexts such as models of carcinogenesis.
Agents that dissolve arterial thrombi
InactiveUS20070009529A1BiocideImmunoglobulins against cell receptors/antigens/surface-determinantsEpitopeThrombus
Owner:NEW YORK UNIV
Composition for reducing cell apoptosis containing avocado and soybean lipid unsaponifiables
A composition for reducing cell apoptosis is disclosed. The composition contains from about 0.01% to about 0.15% of a mixture of avacado lipid unsaponifiables and soybean lipid unsaponifiables which protects against the apoptotic effect of phorbol myristyl acetate (PMA). The composition also prevents the inhibition of cellular aging and for protection of the skin against negative environmental factors and pollutants.
Owner:I M S COSMETICS
Process to produce prostratin and structural or functional analogs thereof
ActiveUS8067632B2Improve propertiesAvoid small quantitiesOrganic compound preparationCarbonyl compound preparationHydrogenDeoxyglucose
This invention concerns a process to convert a hydroxyl group (bold in R3C—OH) in a tigliane-type compound to a hydrogen (bold in R3C—H) to obtain deoxytigliane-type compounds or structural or functional analogs thereof. The process has wide application particularly to produce specific biologically active compounds in quantity for use as pharmaceuticals. In particular the process can be used to convert phorbol to a 12-deoxytigliane (prostrating which is a therapeutic lead for the treatment of AIDS. New compositions of matter are also disclosed.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Method for efficient separation and culture of human primary melanin cells
ActiveCN108192856AImprove separation efficiencyShort training periodCell dissociation methodsEpidermal cells/skin cellsAdditive ingredientClonal growth
The invention belongs to the technical field of cell culture, and in particular relates to a method for efficient separation and culture of human primary melanin cells. According to the method provided by the invention, an ROCK inhibitor is added to a culture medium which consists of the following ingredients: a Ham's F-12 medium, dibutiryl cyclic adenosine monophosphate, 3-isobutyl-1-methylxanthine, sodium orthovanadate, phorbol 12-myristinate 13-acetate, fetal calf serum and double-antibody; on the basis of mutual actions of the various ingredients, the melanin cells can achieve cloning growth, so that a culture cycle can be shortened by half and separation efficiency of the melanin cells can be greatly improved; the separation and culture method provided by the invention is simple and easy to operate and is low in amount of medium ingredients; and large-scale production of the human primary melanin cells is achieved.
Owner:SHANDONG UNIV
Oocyte activating solution and application thereof
ActiveCN111944744AEfficient activationNo biohazardClimate change adaptationCulture processIonomycinAnimal science
The invention belongs to the technical field of assisted reproduction, and relates to an oocyte activating solution and application thereof. The oocyte activating solution comprises 1.1 to 1.8 mg / L ofionomycin, 6 to 12 mg / L of calcium ion carrier A23187, 63 to 94 mug / L of puromycin, 19 to 43 mg / L of 6DMAP, 3.4 to 6.6 mg / L of actinone CHX, 28 to 53 mug / L of phorbol PMA, 7.8 to 12.7 mug / L of inositol triphosphate, 1.5 to 2.4 g / L of SrCl2, 16 to 25 mg / L of heparin, and basic culture medium. The oocyte activating solution can effectively activate oocytes, and is suitable for activating the oocytes after ICSI in an in-vitro fertilization assisted reproduction technology.
Owner:成都艾伟孚生物科技有限公司
Process to Produce Prostratin and Structural or Functional Analogs Thereof
ActiveUS20090187046A1Improved therapeutic propertyAvoid small quantitiesOrganic compound preparationCarbonyl compound preparationHydrogenDeoxyglucose
This invention concerns a process to convert a hydroxyl group (bold in R3C—OH) in a tigliane-type compound to a hydrogen (bold in R3C—H) to obtain deoxytigliane-type compounds or structural or functional analogs thereof. The process has wide application particularly to produce specific biologically active compounds in quantity for use as pharmaceuticals. In particular the process can be used to convert phorbol to a 12-deoxytigliane (prostrating which is a therapeutic lead for the treatment of AIDS. New compositions of matter are also disclosed.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Conversion method for euphorbia lathyris phorbol derivative and use thereof for preparing antitumor drug
ActiveCN107164422AGood antitumor activityEster active ingredientsChemical recyclingMicroorganismMicrobial transformation
The invention belongs to the technical field of the biological medicine, and relates to a microbial conversion method for a euphorbia lathyris diterpene compound. The method comprises the following steps: performing the microbial conversion to euphorbia lathyris phorbol and 7-hydroxy euphorbia lathyris phorbol by using Nocard's bacillus (i) Nocardia sp. ( / i) NRRL 5646, and preparing 3-carbonyl euphorbia lathyris phorbol and 7-acetoxyl euphorbia lathyris phorbol derivatives. Proved by the experiment, the polarity of the 3-carbonyl euphorbia lathyris phorbol in the derivative is reduced. Compared with a substrate, the derivative has the better cytotoxic activity. The derivative is an antitumor lead compound with development value.
Owner:FUDAN UNIV
Diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same
InactiveCN104011009AAvoid infectionEffective in the prevention of viral infectious diseasesOrganic active ingredientsOrganic chemistryViral infectious diseaseCvd risk
The present invention relates to a fluidic phorbol type diterpene compound, a pharmaceutical composition for treatment or prevention of viral infectious diseases including the same, a health functional food for prevention or improvement of the viral infectious diseases, and a composition for enhanced production of interferon-gamma. Furthermore, the present invention relates to a method for prevention or treatment of the viral infectious diseases including a step of injecting the composition into an entity having an occurrence or risk of the viral infectious diseases with a therapeutically effective dose.
Owner:KOREA RES INST OF BIOSCIENCE & BIOTECHNOLOGY
Agents that dissolve arterial thrombi
InactiveUS20110052594A1Immunoglobulins against cell receptors/antigens/surface-determinantsAntibody ingredientsEpitopeThrombus
Owner:NEW YORK UNIV
Conversion preparation method of euphorbia lathyris diterpene compound
ActiveCN106701847AOrganic active ingredientsMicroorganism based processesSolubilityMicrobial transformation
The invention relates to the field of biological medicines, and relates to a conversion method of a euphorbia lathyris diterpene compound. The method comprises the following steps of utilizing a known microorganism to perform microorganism conversion on the euphorbia lathyris phorbol and a derivative thereof, and combining with chemical acylation, so as to prepare a euphorbia lathyris diterpene derivative compound; especially, utilizing a mucor circinelloides (CICC40242) microorganism to perform hydroxylation biological conversion on the euphorbia lathyris phorbol and euphorbia factor L3, and performing chemical acylation on hydroxyls introduced by C8 and C18, so as to obtain three hydroxylated products and six C8 alcohol esterified products. The method has the advantages that the water solubility of the euphorbia factor L3 is improved by the hydroxylation at site, and the druggability is improved; furthermore, the prepared euphorbia lathyris diterpene compound can be used for preparing anti-tumor activity and anti-tumor multidrug resistance type pharmaceutical compositions. The chemical formula is shown in the specification.
Owner:FUDAN UNIV
Low-temperature preservation and transportation culture medium
ActiveCN111100838ALong-term organizational vitalityIncrease energy metabolismEpidermal cells/skin cellsCulture processSucroseVitamin C
The invention provides a low-temperature preservation and transportation culture medium. The low-temperature preservation and transportation culture medium comprises the following components: a melanin skin model culture solution, a buffer system, agarose, sucrose, glycine, adenosine, alpha-tocopherol, vitamin C, sphingosine-1-phosphoric acid, Y-27632 and heparin, wherein the melanin skin model culture solution comprises a basic culture solution, hydrocortisone, insulin, growth factors, epinephrine, 12-myristic acid-13-phorbol acetate, stem cell factors, glutamine, calcium chloride and antibiotics.
Owner:GUANGDONG BOXI BIO TECH CO LTD
Method for the production of thymocyte supernatant
PendingUS20200165566A1Robust processingIncrease the number ofCulture processBlood/immune system cellsPhytohemagglutinin-MThymus Glands
Herein is reported a method for producing a thymocyte supernatant comprising the steps of co-cultivating thymocytes and mononuclear cells at a cell ratio of at least 0.5:1.2 in the presence of phorbol-12-myristate-13-acetate and Phytohemagglutinin M for up to 60 hours, and separating the co-cultivation medium from the cells and thereby producing the thymocyte supernatant.
Owner:F HOFFMANN LA ROCHE & CO AG
Targeting nanomaterial with cell membrane coated with Au-Fe3O4 as well as preparation method and application of targeting nanomaterial
ActiveCN112791062AGood curative effectGive full play to the therapeutic effectHeavy metal active ingredientsMaterial nanotechnologyCancer cellCell membrane
The invention provides a targeting nanomaterial with a cell membrane coated with Au-Fe3O4 as well as a preparation method and application of the targeting nanomaterial, belonging to the technical field of targeting nanomaterials. The targeting nanomaterial provided by the invention comprises a cancer cell membrane, Au-Fe3O4 nanoparticles, tannic acid and phorbol 12-myristate 13-acetate, wherein the Au-Fe3O4 nanoparticles, the tannic acid and the phorbol 12-myristate 13-acetate are wrapped in the cancer cell membrane. PMA can effectively stimulate cells to generate H2O2 and active oxygen O2 <->, can supplement insufficient H2O2 in cancer cells, and can supplement raw materials for Fenton reaction; the Fe3O4 can be partially decomposed in the presence of the tannic acid to form Fe<2+> and Fe<3+>, Fe<2+> can catalyze H2O2 in the cancer cells to be decomposed into hydroxyl radicals, and TA can promote rapid conversion of Fe<3+> generated by Fe3O4 into Fe<2+>; and meanwhile, Au and Fe3O4 have good photo-thermal conversion efficiency, and can give full play to the therapeutic effect of PTT.
Owner:山东济清科技服务有限公司
Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same
ActiveUS20140364492A1Induce productionEffective treating and preventingBiocideOrganic chemistryViral infectious diseaseInterferon alpha
The present invention relates to a diterpene compound derived from Aleurites fordii, and a pharmaceutical composition for treating or preventing viral infectious diseases, a health functional food for preventing or ameliorating viral infectious diseases and a composition for enhancing the production of interferon-gamma, which comprise the diterpene compound. Furthermore, the present invention relates to a method for preventing or treating viral infectious diseases including administering the composition to a subject having a viral infectious disease occurrence or a risk thereof with a therapeutically effective dose.
Owner:KOREA RES INST OF BIOSCI & BIOTECH
Method for evaluating immunomodulatory function of substance
PendingCN114085813AAccurate evaluationImmunomodulatory function is accurateMicrobiological testing/measurementGenetically modified cellsIonomycinTransgene
The invention discloses a method for evaluating the immunomodulatory function of a substance, which comprises the following steps: preparing a primary natural immune cell suspension from the spleen of an acquired immune cell deficient mouse; culturing the immune cells and OVA to obtain a culture system; collecting spleen and lymph node single-cell suspensions of a T cell receptor transgenic mouse, and carrying out magnetic bead sorting to obtain CD4 + CD62L + Naive T cells; adding the CD4 + CD62L + Naive T cells into the culture system, and adding a substance to be evaluated into the culture system at the concentration of 100-500mu g / mL in the culture process; collecting all cells, performing stimulation culture on the cells by using phorbol and ionomycin, performing membrane rupture, matching and fixing, adding a fluorescent antibody, and detecting the proportion of Th1, Th2 or Treg by using a flow cytometer so as to evaluate the immunomodulatory function of the substance. The method can accurately evaluate whether the active substance has the immune regulation function, and is low in cost and short in period.
Owner:JIMEI UNIV +1
Extraction method for phorbol
InactiveCN108821958AReduce dosageSimple extraction processCarbonyl compound separation/purificationSolventAlkaline hydrolysis
The invention provides an extraction method for phorbol to overcome the problems that conventional silica gel column chromatography is employed for phorbol extraction in the prior art and consumes a large amount of solvents and conventional extraction processes are complicated and have low purification efficiency. The extraction method for phorbol in the invention comprises the following steps: (1) weighing the seeds of Jatropha carcass and carrying out physical pulverization; (2) carrying out refluxing with an ethanol solution, then carrying out extraction, and then concentrating the obtainedextract until the extract is dry; (3) extracting a product concentrated to dryness in the step (2) with ethyl acetate and then carrying out concentration to dryness; (4) weighing a concentrated product obtained in the step (3), adding a sodium hydroxide solution and carrying out stirring until TLC shows that alkaline hydrolysis is completed; and (5) subjecting a crystallization product obtained in the step (4) to recrystallization with absolute ethanol so as to obtain a white needle crystal.
Owner:湖州展舒生物科技有限公司
Barbadosnut phorbol ester water emulsion insecticide and preparation method thereof
The invention discloses a barbadosnut phorbol ester water emulsion insecticide. The barbadosnut phorbol ester water emulsion insecticide comprises the following components by weight: 1-20 percent of barbadosnut phorbol ester, 5-20 percent of a solvent, 3-20 percent of an emulsifier, 5-20 percent of a cosolvent, 2-5 percent of an antifreeze, 2-15 percent of a stabilizer, and the balance of water. The invention further discloses a preparation method of the barbadosnut phorbol ester water emulsion insecticide. Due to the fact that effective component of the product provided by the invention is phorbol ester extracted from barbadosnut seed oil and obtained as one of the side products generated producing a biodiesel, not only the barbadosnut resource is used comprehensively and the gap of using phorbol ester as the environment-friendly botanic pesticides is filled, but also the source of raw materials is wide, the cost is low, and the insecticide is easy to degrade and has no pollution to the environment. At the same time, as phorbol ester is a secondary metabolite of the plants, the product is featured with a wide insecticidal spectrum and various use ways, and is convenient to popularize.
Owner:SICHUAN UNIV
A method for establishing a "human-derived" cardiac hypertrophy model based on pluripotent stem cell technology
ActiveCN108913655BCell dissociation methodsSkeletal/connective tissue cellsPluripotential stem cellMedicine
Owner:ZHEJIANG UNIV
A Bulk Hemichannel Functional Level Detection Method Based on Fluorescent Dye Uptake
ActiveCN113686830BReduce misalignmentEasy to operateFluorescence/phosphorescenceAgainst vector-borne diseasesFluorescent stainingCell biology
A batch half-channel functional level detection method based on fluorescent dye uptake: (1) suspension culture, take THP-1 cells of a suspension culture cell line, use RPMI1640 culture medium supplemented with β-mercaptoethanol, and periodically add or replace the culture medium to protect cells The living environment is stable; monitor the concentration of the cell suspension does not exceed 1 × 10 6 cells / ml; the concentration of cell suspension was adjusted to 4×10 5 cells / ml, add tetradecanoyl phorbol acetate, inoculate the cell suspension in a 96-well plate, and change the medium after 24 hours to remove non-adherent cells; use blank RPMI1640 medium to maintain the culture to remove tetradecanoyl phorbol The effect of boitol acetate; (2) Fluorescent dye uptake to detect hemi-channel activity, ethidium bromide is a fluorescent dye, use standard RPMI1640 culture medium to prepare ethidium bromide fluorescent staining stock solution, and ethidium bromide staining stock solution The 96-well plate was added to the 96-well plate. After adding the fluorescent dye solution, the 96-well plate was placed on ice and incubated in the dark. The 96-well plate was placed in a fluorescence microplate reader to detect the fluorescence intensity.
Owner:CHINESE RES ACAD OF ENVIRONMENTAL SCI
Preparation method and use of nanometer targeting preparation of micro-molecular immune drug
InactiveCN107510651ASolve the problem of water solubilityImprove tolerancePowder deliveryPharmaceutical non-active ingredientsSolubilityActive component
The invention relates to a construction method and a use of a nanometer targeting preparation of a micro-molecular immune drug. Ingenol phorbol angelate which cannot be dissolved in water and only can be administrated in a skin smearing manner as a gel, and its derivatives are loaded to a carrier auxiliary material to form nanometer particles, and then the nanometer particles are lyophilized to form a powder injection, so the water solubility problem is solved, the stability of the active components of the micro-molecular immune drug is improved, the problem of no vein administration or tumor interventional administration due to too high hydrophobicity and toxicity is solved, and the use of the micro-molecular immune drug is expanded.
Owner:王成
A cell membrane-coated au-fe 3 o 4 Targeted nanomaterials and their preparation methods and applications
ActiveCN112791062BGood curative effectGive full play to the therapeutic effectMaterial nanotechnologyHeavy metal active ingredientsCancer cellCell membrane
Owner:山东济清科技服务有限公司
Method for separating phorbol alcohol by ultrasonic-assisted alcoholysis-extraction coupling technology
ActiveCN111138263BHigh purityReduce consumptionOrganic compound preparationCarbonyl compound separation/purificationUltrasound - actionAlcohol
Owner:NANCHANG UNIV
Method for eliminating alpha-synuclein generated in Parkinson's model cells by using cadmium telluride quantum dots and application thereof
ActiveCN103013922BGood biocompatibilityEfficient removalTumor/cancer cellsCulture mediumsSynaptic protein
The invention relates to a method for eliminating alpha-synuclein generated in Parkinson's model cells by using cadmium telluride quantum dots and application thereof. The method comprises the following steps: spreading a cell suspension obtained by Parkinson's model cell digestion into 6 pore plates, wherein 3*10<4>-3*10<5> cells are spread in each hole; and after the cells are attached to walls, removing the culture medium in the hole, and adding a culture medium containing 4-75nM cadmium telluride quantum dots, thereby obviously eliminating the overexpressed alpha-synuclein in the Parkinson's model cells under the action of the cadmium telluride quantum dots. The Parkinson's model cells are SH-SY5Y cells which are constructed in vitro from 1-methyl-4-phenyl-pyridine ions and subjected to induced differentiation with all-trans-vitamin A acid and tetradecanoyl phorbol acetate, or differentiated PC12 cells constructed in vitro from 1-methyl-4-phenyl-pyridine ions. Cadmium telluride quantum dots with favorable biocompatibility are utilized to induce autophagy effect of cells, thereby eliminating overexpressed toxic protein (alpha-synuclein) in the Parkinson's model cell.
Owner:SHANGHAI INST OF APPLIED PHYSICS - CHINESE ACAD OF SCI
Method for extracting phorbol from croton oil by using Girard's reagent
InactiveCN111269102AHigh purityHigh degreeCarbonyl compound separation/purificationFiltrationSolvent
The invention relates to the technical field of natural medicine extraction, and particularly discloses a method for extracting phorbol from croton oil by using a Girard's reagent. The method comprises the following steps: S1, mixing 1 part of croton oil with 5-25 parts of a methanol saturated solution of a Girard's reagent according to a feed liquid volume ratio, and carrying out a stirring reaction at 18-50 DEG C for 30-180 min to obtain a reaction solution; S2, concentrating a reaction solution; S3, extracting and removing croton oil by using petroleum ether to obtain a water phase containing the phorbol Girard's reagent salt; S4, adjusting the pH value to 2-3, and extracting the phorbol in the water phase by using petroleum ether; S5, concentrating the petroleum ether phase to obtain an oily substance; and S6, carrying out alcoholysis, acidification and filtration on the oily substance to obtain a crude product of the phorbol. According to the method, carbonyl reacts with a Girard's reagent, and then a large amount of impurities can be removed by an extraction method due to different polarities of the components, so that a crude product of the phorbol with relatively high purity is obtained. The method has the characteristics of simplicity and convenience in operation, short time consumption and low solvent consumption, and is easy to popularize and apply industrially.
Owner:NANCHANG UNIV
Application of phenformin as skin anti-inflammatory preparation
The invention discloses application of phenformin as a skin anti-inflammatory preparation. First discovery finds that the phenformin can be used for obviously inhibiting skin epidermic cells from secreting various inflammatory cell factors including 6 / 8(IL-6, IL-8) and tumor necrosis factors (TNF alpha), and similarly inflammatory response of human skin epithelial cells induced by frequently-used 12-oxy-tetradecanoyl phorbol-13-acetate (TPA) and poly-poly(C) polyinosinic-polycytidylic acid (poly I:C) (immunologic stimulant), so that the phenformin can be used for preventing and curing related diseases of skin inflammation. Therefore, novel application is developed for the phenformin, and new prevention and treatment means is provided for related diseases of skin inflammation.
Owner:SHANDONG UNIV
Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same
InactiveUS9174925B2Effective treating and preventingIncrease productionOrganic active ingredientsOrganic chemistryViral infectious diseaseInterferon alpha
The present invention relates to a diterpene compound derived from Aleurites fordii, and a pharmaceutical composition for treating or preventing viral infectious diseases, a health functional food for preventing or ameliorating viral infectious diseases and a composition for enhancing the production of interferon-gamma, which comprise the diterpene compound. Furthermore, the present invention relates to a method for preventing or treating viral infectious diseases including administering the composition to a subject having a viral infectious disease occurrence or a risk thereof with a therapeutically effective dose.
Owner:KOREA RES INST OF BIOSCI & BIOTECH
Batch half-channel function level detection method based on fluorescent dye uptake
ActiveCN113686830AReduce misalignmentEasy to operateFluorescence/phosphorescenceAgainst vector-borne diseasesFluorescent stainingCell biology
The invention relates to batch half-channel function level detection method based on fluorescent dye uptak. The method comprises the steps: (1) suspension culture: taking THP-1 cells of a suspension culture cell line, using an RPMI1640 culture solution added with beta-mercaptoethanol, and regularly adding or replacing the culture solution to ensure the steady state of the living environment of the cells; monitoring that the concentration of the cell suspension does not exceed 1 * 10 < 6 > / ml; adjusting the concentration of the cell suspension to be 4 * 10 < 5 > / ml, adding tetradecanoyl phorbol acetate, inoculating the cell suspension to a 96-well plate, and changing the solution 24 hours later to remove non-adherent cells; using a blank RPMI1640 culture solution for maintaining culture so as to remove the action effect of tetradecanoyl phorbol acetate; and (2) taking in a fluorescent dye to detect the activity of the semi-channel, taking ethidium bromide as the fluorescent dye, preparing an ethidium bromide fluorescent staining stock solution by using a standard RPMI1640 culture solution, adding the ethidium bromide fluorescent staining stock solution into a 96-well plate, adding the fluorescent staining solution, placing the 96-well plate on ice, incubating in a dark place, and placing the 96-well plate into a fluorescence microplate reader to detect the fluorescence intensity result.
Owner:CHINESE RES ACAD OF ENVIRONMENTAL SCI
Conversion method of caperia diterpene alcohol derivatives and its use in the preparation of antitumor drugs
ActiveCN107164422BGood antitumor activityEster active ingredientsChemical recyclingMicrobial transformationPharmaceutical Substances
Owner:FUDAN UNIV
A method for efficiently isolating and culturing human primary melanocytes
ActiveCN108192856BImprove separation efficiencyShort training periodCell dissociation methodsEpidermal cells/skin cellsMethyl xanthineXanthine
A method for separating and culturing human primary melanocytes. According to the method, an ROCK inhibitor is added to a culture medium comprising a Ham's F-12 medium, dibutyryl cyclic adenosine monophosphate, 3-isobutyl-1-methylxanthine, sodium orthovanadate, phorbol 12-myristate 13-acetate, fetal bovine serum, and double antibodies.
Owner:SHANDONG UNIV
Method for separating phorbol by utilizing ultrasonic-assisted alcoholysis-extraction coupling technology
ActiveCN111138263AHigh purityReduce consumptionOrganic compound preparationCarbonyl compound separation/purificationUltrasound - actionAlcohol
The invention relates to the technical field of natural medicine extraction, and particularly discloses a method for separating phorbol by utilizing an ultrasonic-assisted alcoholysis-extraction coupling technology. The method comprises the following steps: S1, uniformly mixing 1 part of croton oil with 5-25 parts of a saturated alkaline alcoholic solution according to a volume ratio of feed liquid, carrying out alcoholysis-extraction under the action of ultrasonic waves, and carrying out standing separation to obtain an alkaline supernatant containing phorbol and a croton oil lower phase liquid; and S2, adjusting the pH value of the obtained alkaline supernatant to be neutral by using an acidic alcohol solution, and removing the obtained precipitate to obtain a neutral alcohol solution containing the phorbol. The ultrasonic-assisted alcoholysis-extraction coupling technology is used for extracting the phorbol from the croton oil, alcoholysis and extraction are carried out synchronously, and alcoholysis-extraction coupling is carried out, so the alcoholysis efficiency is improved advantageously, alcoholysis-extraction is fast and efficient under the assistance of ultrasonic waves,time is saved, and the purity of the phorbol is improved. The method has the advantages of few operation steps, short time consumption, low solvent consumption and easiness in promotion and application.
Owner:NANCHANG UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com